SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
isopatch
roguedolphin
To: Tenchusatsu who wrote (1341263)2/4/2022 9:19:06 PM
From: h_2 Recommendations   of 1573198
 
Page 18

High quality safety science would have meant they should have tested before & after inoculation for: • d-dimers for evidence of enhanced coagulation/clotting (several of our doctors have noticed increased levels of d-dimers in inoculated patients presenting with stroke like symptoms - video available here)
• C-reactive protein for evidence of enhanced inflammation
• troponins for evidence of cardiac damage
• occludin and claudin for evidence of enhanced barrier permeability
• blood oxygen levels for evidence of enhanced hypoxia
• amyloid-beta and phosphorylated tau for evidence of increased predisposition to Alzheimer’s disease
• Serum HMGB1, CXCL13, Dickkopf-1 for evidence of an increased disposition to autoimmune disease, etc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext